Literature DB >> 33573353

ER Stress and Unfolded Protein Response in Leukemia: Friend, Foe, or Both?

Kelly Féral1,2, Manon Jaud1,2, Céline Philippe3, Doriana Di Bella3, Stéphane Pyronnet1,2, Kevin Rouault-Pierre3, Laurent Mazzolini1,4, Christian Touriol1,2.   

Abstract

The unfolded protein response (UPR) is an evolutionarily conserved adaptive signaling pathway triggered by a stress of the endoplasmic reticulum (ER) lumen compartment, which is initiated by the accumulation of unfolded proteins. This response, mediated by three sensors-Inositol Requiring Enzyme 1 (IRE1), Activating Transcription Factor 6 (ATF6), and Protein Kinase RNA-Like Endoplasmic Reticulum Kinase (PERK)-allows restoring protein homeostasis and maintaining cell survival. UPR represents a major cytoprotective signaling network for cancer cells, which frequently experience disturbed proteostasis owing to their rapid proliferation in an usually unfavorable microenvironment. Increased basal UPR also participates in the resistance of tumor cells against chemotherapy. UPR activation also occurs during hematopoiesis, and growing evidence supports the critical cytoprotective role played by ER stress in the emergence and proliferation of leukemic cells. In case of severe or prolonged stress, pro-survival UPR may however evolve into a cell death program called terminal UPR. Interestingly, a large number of studies have revealed that the induction of proapoptotic UPR can also strongly contribute to the sensitization of leukemic cells to chemotherapy. Here, we review the current knowledge on the consequences of the deregulation of UPR signaling in leukemias and their implications for the treatment of these diseases.

Entities:  

Keywords:  ALL; AML; CLL; CML; endoplasmic reticulum stress; leukemia; unfolded protein response (UPR)

Mesh:

Substances:

Year:  2021        PMID: 33573353      PMCID: PMC7911881          DOI: 10.3390/biom11020199

Source DB:  PubMed          Journal:  Biomolecules        ISSN: 2218-273X


  264 in total

Review 1.  Molecular biomarkers in acute myeloid leukemia.

Authors:  Jeanette Prada-Arismendy; Johanna C Arroyave; Sarah Röthlisberger
Journal:  Blood Rev       Date:  2016-09-02       Impact factor: 8.250

2.  Curcumin sensitizes acute promyelocytic leukemia cells to unfolded protein response-induced apoptosis by blocking the loss of misfolded N-CoR protein.

Authors:  Angela Ping Ping Ng; Wee Joo Chng; Matiullah Khan
Journal:  Mol Cancer Res       Date:  2011-05-20       Impact factor: 5.852

3.  Modest Declines in Proteome Quality Impair Hematopoietic Stem Cell Self-Renewal.

Authors:  Lorena Hidalgo San Jose; Mary Jean Sunshine; Christopher H Dillingham; Bernadette A Chua; Miriama Kruta; Yuning Hong; Danny M Hatters; Robert A J Signer
Journal:  Cell Rep       Date:  2020-01-07       Impact factor: 9.423

4.  Autocrine control of glioma cells adhesion and migration through IRE1α-mediated cleavage of SPARC mRNA.

Authors:  Nicolas Dejeans; Olivier Pluquet; Stéphanie Lhomond; Florence Grise; Marion Bouchecareilh; Amélie Juin; Maud Meynard-Cadars; Aurélien Bidaud-Meynard; Catherine Gentil; Violaine Moreau; Frédéric Saltel; Eric Chevet
Journal:  J Cell Sci       Date:  2012-06-20       Impact factor: 5.285

5.  Bortezomib Causes ER Stress-related Death of Acute Promyelocytic Leukemia Cells Through Excessive Accumulation of PML-RARA.

Authors:  Mariko Takenokuchi; Kazuhide Miyamoto; Katsuyasu Saigo; Taizo Taniguchi
Journal:  Anticancer Res       Date:  2015-06       Impact factor: 2.480

6.  XBP1U inhibits the XBP1S-mediated upregulation of the iNOS gene expression in mammalian ER stress response.

Authors:  Fengjin Guo; Edward A Lin; Ping Liu; Jianwei Lin; Chuanju Liu
Journal:  Cell Signal       Date:  2010-07-15       Impact factor: 4.315

Review 7.  Chronic lymphocytic leukemia: a clinical and molecular heterogenous disease.

Authors:  Ana E Rodríguez-Vicente; Marcos González Díaz; Jesús M Hernández-Rivas
Journal:  Cancer Genet       Date:  2013-03-24

8.  PERK-dependent activation of Nrf2 contributes to redox homeostasis and cell survival following endoplasmic reticulum stress.

Authors:  Sara B Cullinan; J Alan Diehl
Journal:  J Biol Chem       Date:  2004-02-20       Impact factor: 5.157

9.  Targeting of BCR-ABL1 and IRE1α induces synthetic lethality in Philadelphia-positive acute lymphoblastic leukemia.

Authors:  Margherita Vieri; Christian Preisinger; Mirle Schemionek; Azam Salimi; John B Patterson; Afshin Samali; Tim H Brümmendorf; Iris Appelmann; Behzad Kharabi Masouleh
Journal:  Carcinogenesis       Date:  2021-02-25       Impact factor: 4.944

View more
  4 in total

Review 1.  Harnessing the power of sphingolipids: Prospects for acute myeloid leukemia.

Authors:  Johnson Ung; Su-Fern Tan; Todd E Fox; Jeremy J P Shaw; Luke R Vass; Pedro Costa-Pinheiro; Francine E Garrett-Bakelman; Michael K Keng; Arati Sharma; David F Claxton; Ross L Levine; Martin S Tallman; Myles C Cabot; Mark Kester; David J Feith; Thomas P Loughran
Journal:  Blood Rev       Date:  2022-04-09       Impact factor: 10.626

2.  Anti-Growth, Anti-Angiogenic, and Pro-Apoptotic Effects by CX-4945, an Inhibitor of Casein Kinase 2, on HuCCT-1 Human Cholangiocarcinoma Cells via Control of Caspase-9/3, DR-4, STAT-3/STAT-5, Mcl-1, eIF-2α, and HIF-1α.

Authors:  Saini Wang; Anil Kumar Yadav; Jin-Yi Han; Keun Soo Ahn; Byeong-Churl Jang
Journal:  Int J Mol Sci       Date:  2022-06-06       Impact factor: 6.208

3.  GSDMD enhances cisplatin-induced apoptosis by promoting the phosphorylation of eIF2α and activating the ER-stress response.

Authors:  Qianyu Zhang; Zixian Huang; Xi Rui; Yan Wang; Yongqiang Wang; Yuwei Zhou; Rui Chen; Yongju Chen; Yuepeng Wang; Shihao Li; Haigang Li; Ximing Shen; Yancan Liang; Yin Zhang; Zhiquan Huang
Journal:  Cell Death Discov       Date:  2022-03-14

Review 4.  Circular RNAs Activity in the Leukemic Bone Marrow Microenvironment.

Authors:  Francesca Liccardo; Alessia Iaiza; Martyna Śniegocka; Silvia Masciarelli; Francesco Fazi
Journal:  Noncoding RNA       Date:  2022-07-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.